|
|
||||||||
RESEARCH AND PRACTICE |
Joseph G. Feldman is with the Department of Preventive Medicine and Community Health, SUNY Health Sciences Center at Brooklyn, New York, NY. Howard Minkoff is with the Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Health Sciences Center at Brooklyn. Michael F. Schneider and Stephen J. Gange are with the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. Mardge Cohen is with Cook County Hospital, Chicago, Ill. D. Heather Watts is with Pediatric, Adolescent and Maternal AIDS, National Institute of Child Health and Human Development, Bethesda, Md. Monica Gandhi is with the Department of Medicine, University of California, San Francisco, Calif. Robert S. Mocharnuk is with the University of Southern California, Keck School of Medicine, Los Angeles. Kathryn Anastos is with the departments of Medicine and Epidemiology and Population Health, Montefiore Medical Center, Bronx, NY.
Correspondence: Requests for reprints should be sent to Joseph G. Feldman, Box 43 SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203 (e-mail: joseph.feldman{at}downstate.edu).
Objective. We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women.
Methods. Data were analyzed from the Womens Interagency HIV Study, a multisite longitudinal study up to 7.9 years for 924 women representing 72% of all women who initiated HAART between July 1, 1995, and September 30, 2003.
Results. When Coxs regression was used after control for age, race, hepatitis C infection, illicit drug use, previous antiretroviral therapy, and previous AIDS, smokers on HAART had poorer viral responses (hazard ratio [HR]=0.79; 95% confidence interval [CI]=0.67, 0.93) and poorer immunologic response (HR=0.85; 95% CI=0.73, 0.99). A greater risk of virologic rebound (HR=1.39; 95% CI=1.06, 1.69) and more frequent immunologic failure (HR=1.52; 95% CI=1.18, 1.96) were also observed among smokers. There was a higher risk of death (HR=1.53; 95% CI=1.08, 2.19) and a higher risk of developing AIDS (HR=1.36; 95% CI=1.07, 1.72) but no significant difference between smokers and nonsmokers in the risk of death due to AIDS.
Conclusions. Some of the benefits provided by HAART are negated in cigarette smokers.
This article has been cited by other articles:
![]() |
M. Bloch, F. Althabe, M. Onyamboko, C. Kaseba-Sata, E. E. Castilla, S. Freire, A. L. Garces, S. Parida, S. S. Goudar, M. M. Kadir, et al. Tobacco Use and Secondhand Smoke Exposure During Pregnancy: An Investigative Survey of Women in 9 Developing Nations Am J Public Health, October 1, 2008; 98(10): 1833 - 1840. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |